Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

There is no significant link between male pattern baldness and insulin resistance.

More research is needed to determine if iron deficiency causes hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.